Amorphex is a company developing platform technology for ocular drug delivery. It offers TODDD, a soft, patented device that can deliver a drug to the eye continuously, around the clock for multiple months without interruption. The device is worn by the patient under their eyelid and is replaced at prescribed intervals of months or weeks, depending on the treated condition.